Insider · CIK 0001854586

Chu Yu-Waye

Reports to the SEC for 2 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001854586

Forms 4 and 5

Insider transactions

36 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-17	CTMXCytomX Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−21.3K sh	$6.42	−$137K	189,446
2026-02-02	CTMXCytomX Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+75K sh	—	—	210,725
2026-02-02	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+300K sh	—	—	300,000
2025-09-26	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+87.5K sh	—	—	87,500
2025-09-26	CTMXCytomX Therapeutics, Inc. · Performance Stock Units (PSUs)A Award	Chief Medical Officer	AAward	+43.8K sh	—	—	43,750
2025-03-18	CTMXCytomX Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−4,025 sh	$0.60	−$2,410.975	135,725
2025-02-04	CTMXCytomX Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+57.5K sh	—	—	139,750
2025-02-04	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+115K sh	—	—	115,000
2025-02-04	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+238K sh	—	—	238,000
2025-02-04	CTMXCytomX Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+56K sh	—	—	82,250
2024-01-18	CTMXCytomX Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+26.3K sh	—	—	26,250
2024-01-18	CTMXCytomX Therapeutics, Inc. · Performance Stock Units (PSUs)A Award	Chief Medical Officer	AAward	+75K sh	—	—	75,000
2024-01-18	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+123K sh	—	—	122,500
2023-07-19	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+375K sh	—	—	375,000
2023-04-18	FATEFATE THERAPEUTICS INCS Sale	Chief Medical Officer	SSale	−2,317 sh	$6.58	−$15.2K	140,676
2023-04-18	FATEFATE THERAPEUTICS INCS Sale	Chief Medical Officer	SSale	−215 sh	$6.52	−$1,401.8	142,993
2023-02-06	FATEFATE THERAPEUTICS INC · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+425K sh	—	—	425,000
2023-01-10	FATEFATE THERAPEUTICS INCS Sale	Chief Medical Officer	SSale	−7,825 sh	$5.24	−$41K	143,208
2022-04-19	FATEFATE THERAPEUTICS INCS Sale	Chief Medical Officer	SSale	−4,062 sh	$35.37	−$144K	151,033
2022-01-25	FATEFATE THERAPEUTICS INC · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+53.1K sh	—	—	53,058
2022-01-25	FATEFATE THERAPEUTICS INCA Award	Chief Medical Officer	AAward	+33.3K sh	—	—	155,095
2022-01-11	FATEFATE THERAPEUTICS INCS Sale	Chief Medical Officer	SSale	−418 sh	$49.10	−$20.5K	121,793
2022-01-11	FATEFATE THERAPEUTICS INCS Sale	Chief Medical Officer	SSale	−3,547 sh	$48.44	−$172K	122,211
2021-12-10	FATEFATE THERAPEUTICS INCS Sale	Chief Medical Officer	SSale	−1,031 sh	$53.66	−$55.3K	126,363
2021-12-10	FATEFATE THERAPEUTICS INCS Sale	Chief Medical Officer	SSale	−600 sh	$54.58	−$32.7K	126,763
2021-12-10	FATEFATE THERAPEUTICS INCS Sale	Chief Medical Officer	SSale	−5 sh	$55.54	−$277.7	125,758
2021-12-10	FATEFATE THERAPEUTICS INC · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−7,500 sh	—	—	105,000
2021-12-10	FATEFATE THERAPEUTICS INCM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+7,500 sh	$16.32	+$122K	133,258
2021-12-10	FATEFATE THERAPEUTICS INCS Sale	Chief Medical Officer	SSale	−2,097 sh	$49.32	−$103K	131,161
2021-12-10	FATEFATE THERAPEUTICS INCS Sale	Chief Medical Officer	SSale	−900 sh	$50.42	−$45.4K	130,261
2021-12-10	FATEFATE THERAPEUTICS INCS Sale	Chief Medical Officer	SSale	−1,045 sh	$51.08	−$53.4K	129,216
2021-12-10	FATEFATE THERAPEUTICS INCS Sale	Chief Medical Officer	SSale	−1,822 sh	$52.37	−$95.4K	127,394
2021-11-19	FATEFATE THERAPEUTICS INCA Award	Chief Medical Officer	AAward	+61K sh	—	—	125,758
2021-04-16	FATEFATE THERAPEUTICS INCS Sale	Chief Medical Officer	SSale	−1,500 sh	$84.41	−$127K	64,800
2021-04-16	FATEFATE THERAPEUTICS INCS Sale	Chief Medical Officer	SSale	−900 sh	$82.91	−$74.6K	66,300
2021-04-16	FATEFATE THERAPEUTICS INCS Sale	Chief Medical Officer	SSale	−875 sh	$81.80	−$71.6K	67,200

Recent filings

Accepted (ET)
Mar 194
Chu Yu-Waye0001610717-26-000125
SEC(opens sec.gov)
Feb 44
Chu Yu-Waye0001610717-26-000042
SEC(opens sec.gov)
Sep 304
Chu Yu-Waye0001610717-25-000356
SEC(opens sec.gov)
Mar 204
Chu Yu-Waye0001610717-25-000084
SEC(opens sec.gov)
Feb 64
Chu Yu-Waye0001610717-25-000018
SEC(opens sec.gov)
Jan 194
Chu Yu-Waye0001610717-24-000031
SEC(opens sec.gov)
Jul 204
Chu Yu-Waye0001610717-23-000208
SEC(opens sec.gov)
Apr 194
Chu Yu-Waye0001209191-23-024820
SEC(opens sec.gov)
Feb 74
Chu Yu-Waye0001209191-23-007497
SEC(opens sec.gov)
Jan 114
Chu Yu-Waye0001209191-23-002974
SEC(opens sec.gov)
Apr 214
Chu Yu-Waye0001209191-22-025159
SEC(opens sec.gov)
Jan 274
Chu Yu-Waye0000899243-22-003448
SEC(opens sec.gov)

Companies

Address

C/O CYTOMX THERAPEUTICS, INC. 151 OYSTER POINT BLVD, SUITE 400

SOUTH SAN FRANCISCO, CA, 94080